Kwaśniewska, D.; Fudalej, M.; Nurzyński, P.; Badowska-Kozakiewicz, A.; Czerw, A.; Cipora, E.; Sygit, K.; Bandurska, E.; Deptała, A.
How A Patient with Resectable or Borderline Resectable Pancreatic Cancer should Be Treated—A Comprehensive Review. Cancers 2023, 15, 4275.
https://doi.org/10.3390/cancers15174275
AMA Style
Kwaśniewska D, Fudalej M, Nurzyński P, Badowska-Kozakiewicz A, Czerw A, Cipora E, Sygit K, Bandurska E, Deptała A.
How A Patient with Resectable or Borderline Resectable Pancreatic Cancer should Be Treated—A Comprehensive Review. Cancers. 2023; 15(17):4275.
https://doi.org/10.3390/cancers15174275
Chicago/Turabian Style
Kwaśniewska, Daria, Marta Fudalej, Paweł Nurzyński, Anna Badowska-Kozakiewicz, Aleksandra Czerw, Elżbieta Cipora, Katarzyna Sygit, Ewa Bandurska, and Andrzej Deptała.
2023. "How A Patient with Resectable or Borderline Resectable Pancreatic Cancer should Be Treated—A Comprehensive Review" Cancers 15, no. 17: 4275.
https://doi.org/10.3390/cancers15174275
APA Style
Kwaśniewska, D., Fudalej, M., Nurzyński, P., Badowska-Kozakiewicz, A., Czerw, A., Cipora, E., Sygit, K., Bandurska, E., & Deptała, A.
(2023). How A Patient with Resectable or Borderline Resectable Pancreatic Cancer should Be Treated—A Comprehensive Review. Cancers, 15(17), 4275.
https://doi.org/10.3390/cancers15174275